1261289-79-5Relevant articles and documents
CYCLIC COMPOUNDS AND METHODS OF USING SAME
-
Page/Page column 397; 403, (2021/07/02)
The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof which are MALT1 inhibitors. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases, such as cancer, autoimmune disorders, and inflammatory disorders.
AZA-ARYL 1H-PYRAZOL-1-YL BENZENE SULFONAMIDES
-
Paragraph 0191; 0192, (2018/02/28)
Compounds are provided that act as potent antagonists of the CCR(9) receptor for treating Sjogren's syndrome. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions.
SERINE/THREONINE PAK1 INHIBITORS
-
Page/Page column 100-101, (2013/03/26)
Compounds having the formula I wherein A, Z, R1a, R1b, R2, R3, R4, R5, R6, R7, R9, R10, Ra, Rb and n are as defined herein are inhibitors of PAK1. Also disclosed are compositions and methods for treating cancer and hyperproliferative disorders.